Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Amantadine Can Treat Blepharospasm in Levodopa Peak‐Dose Dyskinesia
Amantadine Can Treat Blepharospasm in Levodopa Peak‐Dose Dyskinesia
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Francisco de Assis Aquino Gondim
,
Rodrigo Fagundes da Rosa
,
Francisco Duque de Paiva Giudice Junior
,
João Pedro de Oliveira Gouveia Marcotti
,
Ítalo Ramon de Araújo
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Movement Disorders Clinical Practice
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
Hyperthyroidism Can Precipitate Peak‐Dose Levodopa‐Induced Dyskinesia in Parkinson's Disease
by: Soutarou Taguchi, et al.
Published: (2025)
Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa‐Induced Dyskinesia
by: Yuri L. Sosero, et al.
Published: (2024)
The Role of Basal Ganglia Theta Oscillations in Predicting the Onset of Levodopa‐Induced Dyskinesias
by: Miguel Wilken, et al.
Published: (2025)
Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA Trial
by: Christine Brefel‐Courbon, et al.
Published: (2024)
Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease
by: Maria Teresa Pellecchia, et al.
Published: (2025)